The collaboration will accelerate the testing of GliaPharm’s lead molecules in preclinical models of Alzheimer’s disease and further the development of neuroimaging biomarkers
UNICOR-v has the potential to protect against future epidemics caused by a coronavirus jumping from animals to humans, but also against new variants emerging from SARS-Cov-2
New biotechnology product aims to be world's fastest automatic sanitary solution
he financing was significantly oversubscribed with high demand from both existing and new investors.
Four additional AT2R agonists are expected to finalize preclinical evaluation during 2022
The COVID-19 pandemic has triggered the rapid growth of the biotherapeutics market
Prior to joining Biosion, Edwards was Vice President of Corporate Strategy and operations at Ionis Pharmaceuticals.
He will be responsible for developing the company's pipeline of partnered and in-house discovery programs,
New inhalers would have near-zero Global Warming Potential propellant
The sale is expected to close in the first quarter of 2022
Subscribe To Our Newsletter & Stay Updated
